$0.05

0.001 (2.04%)

Are you using our Portfolio Manager?

Manage your stocks with our free tool.

Get Started

General Information

AtCor Medical Holdings Limited
ACG
http://www.atcormedical.com
Health Care Equipment
11
234

Current Price Data+

Current Price $0.050
Open $0.049
High $0.050
Low $0.049
Last Close $0.048
Volume 181124
Price Movement $0.00 ( 2.04% )
  • +Security prices are delayed by at least 20 minutes and are indicative only.

Company Overview

Business Description

AtCor Medical Holdings Limited (ACG) is an Australia-based company that is a developer and marketer of the SphygmoCor system which measures central blood pressures and arterial stiffness non-invasively.

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2016 A -4.8 -2.4 0.0% 0.0 0.0 0.0% 0.0%
2015 A -1.4 -0.9 0.0% 0.0 0.0 0.0% 0.0%
2014 A -2.7 -1.7 0.0% 0.0 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2014 A 2015 F 2016 F 2014 A 2015 F 2016 F 2014 A 2015 F 2016 F
AtCor Medical (ACG) $11M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Cochlear (COH) $8,776M 0.2951 0.1703 0.1219 46.3091 39.5712 35.2713 1.51% 1.80% 2.04%
Fisher & Paykel Hlth (FPH) $5,779M 0.3370 0.0423 0.2069 33.5759 32.2120 26.6895 1.75% 2.17% 2.62%
Impedimed (IPD) $263M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
ResMed (RMD) $14,193M 0.0603 0.1519 0.1489 29.3548 25.4837 22.1804 1.65% 1.83% 2.05%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 3.08 0.00
Market 0.73 15.80 1.28 1.03
Sector 0.82 20.10 2.23 2.61

Directors

Name Position Start Date
Mr Duncan R Ross Chief Executive Officer, Managing Director 9 Nov 2006
Mr Donal Paul O'Dwyer Non-Executive Chairman 9 Nov 2005
Professor Michael Francis O'Rourke Non-Executive Director 6 Nov 2005
Mr David Lionel Brookes Non-Executive Director 4 Nov 2008
Mr Randall King Nelson Non-Executive Director 13 Nov 2015

Management

Name Position
Peter L Manley Chief Finance Officer,Company Secretary
Doug Kurschinski Senior Vice President and General Manager, AtCor Medical Inc
Mark Harding Vice President, Global Marketing & International Sales, AtCor Medical Pty Ltd

Substantial Shareholders

Holding Name
15,470,000 (7.61%) Cb Co Pty Ltd
15,205,572 (7.48%) National Nominees Limited
10,641,396 (5.24%) Pehila Pty Ltd (O'Rourke Superannuation Fund)

Calendar of Events

Date Event
23 February 2018 Report (Interim)
25 September 2017 Report (Annual)
29 August 2017 Report (Annual)
29 August 2017 Report (Prelim)

© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.